---
title: Drug design idea generation and assay data management
---

Pharma insights, SBDD idea generation, Repurposing usecase, Assay data management, Our blog

| View in browser ▶️ \[Video\] Accelerate Idea Generation in Structure-Based Drug Design How are pharma companies harnessing the potential of 3D protein structures to speed up the ideation process? Watch the full recording of the latest Discngine Labs event and hear from experts from Novo Nordisk, Sanofi, Exscientia, and Chemical Computing Group (CCG) about their experience on ideation in SBDD.   >> Watch now 📢 Discngine Meetup is only 2 weeks away! Join our virtual Meetup event on the topic “New Drug Modalities: Evolving Needs in Scientific Informatics”, which will take place on October 12th at 4 pm CEST. Don't miss the opportunity to have deeper insights into the development of technology that supports the discovery of new modalities and network with peers. Want to join 📊 \[Product\] Discngine Assay 6.2 - What’s new in the new release? We have released a new version of our assay screening data management platform Discngine Assay. Discover the latest enhancements and get a sneak peek into what's coming next.   >> Read more 💡 How to best exploit protein structures for ideation in SBDD (+ drug repurposing use case) Read more about how drug discovery experts are exploiting 3D structures for new drug design and their perspective on how the future of structural data management will evolve.   >> Read blog post >> Watch a use case video 🚀 From legacy system to Discngine Assay: 5 steps to enhance assay data management Check our blog on what are the 5 steps Discngine is taking to enhance assay data management:   >> Read blog post Useful Links 3decision Science Blog Protein of the Month Discngine Blog Discngine YouTube Channel Enjoyed our Newsletter? Don't hesitate to share with your colleagues and follow us on social media.  The Discngine Crew Discngine, 79 Avenue Ledru Rollin, Paris, Ile de France 75012, France, 01 80 48 66 70 Unsubscribe Manage preferences |
| --- |